Leukotriene D4 enhances tumor necrosis factor-α-induced vascular endothelial growth factor production in human monocytes/macrophages

Cytokine

Volumn 55, Issue 1, 2011, Pages 24-28

  Haneda, Yasuhiro ^a   Hasegawa, Shunji ^a   Hirano, Reiji ^a   Hashimoto, Kunio ^a   Ohsaki, Ayami ^a   Ichiyama, Takashi ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

LTD4; Macrophages; Monocytes; VEGF

Indexed keywords

CD14 ANTIGEN; LEUKOTRIENE D4; MESSENGER RNA; PRANLUKAST; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CHROMONE DERIVATIVE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; MACROPHAGE; MONOCYTE; MONOCYTIC LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ANTIGENS, CD14; CELL LINE; CHROMONES; GENE EXPRESSION REGULATION; HUMANS; LEUKOTRIENE D4; MACROPHAGES; MONOCYTES; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79956365071     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.03.018     Document Type: Article

References (44)

1. Ferrara N., Henzel W. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989, 161:851-858.
2. Leung D., Cachianes G., Kuang W., Goeddel D., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246:1306-1309.
3. Hoshino M., Takahashi M., Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001, 107:295-301.
4. Asai K., Kanazawa H., Otani K., Shiraishi S., Hirata K., Yoshikawa J. Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. J Allergy Clin Immunol 2002, 110:571-575.
5. Asai K., Kanazawa H., Kamoi H., Shiraishi S., Hirata K., Yoshikawa J. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy 2003, 33:595-599.
6. Kanazawa H., Hirata K., Yoshikawa J. Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients. Thorax 2002, 57:885-888.
7. Senger D., Galli S., Dvorak A., Perruzzi C., Harvey V., Dvorak H. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985.
8. Connolly D., Olander J., Heuvelman D., Nelson R., Monsell R., Siegel N., et al. Human vascular permeability factor, isolation from U937 cells. J Biol Chem 1989, 264:20017-20024.
9. Nakai H., Konno M., Kosuge S., Sakuyama S., Toda M., Arai Y., et al. New potent antagonists of leukotrienes C4 and D4. 1. Synthesis and structure-activity relationships. J Med Chem 1988, 31:84-91.
10. Diamant Z., Hiltermann J., van Rensen E., Callenbach P., Veselic-Charvat M., van der Veen H., et al. The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma. Am J Respir Crit Care Med 1997, 155:1247-1253.
11. Henderson W.J., Tang L., Chu S., Tsao S., Chiang G., Jones F., et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002, 165:108-116.
12. Figueroa D., Breyer R., Defoe S., Kargman S., Daugherty B., Waldburger K., et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 2001, 163:226-233.
13. Lee K., Kim S., Park H., Jin G., Lee Y. Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expression. J Allergy Clin Immunol 2004, 114:1093-1099.
14. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980, 26:171-176.
15. Hoshino M., Izumi T., Shimizu T. Leukotriene D4 activates mitogen-activated protein kinase through a protein kinase Calpha-Raf-1-dependent pathway in human monocytic leukemia THP-1 cells. J Biol Chem 1998, 273:4878-4882.
16. Hashimoto K., Ichiyama T., Hasegawa M., Hasegawa S., Matsubara T., Furukawa S. Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappaB pathways. Int Arch Allergy Immunol 2009, 149:275-282.
17. Ichiyama T., Hasegawa M., Hashimoto K., Matsushige T., Hirano R., Furukawa S. Cysteinyl leukotrienes induce macrophage inflammatory protein-1 in human monocytes/macrophages. Int Arch Allergy Immunol 2009, 148:147-153.
18. Ichiyama T., Kajimoto M., Hasegawa M., Hashimoto K., Matsubara T., Furukawa S. Cysteinyl leukotrienes enhance tumour necrosis factor-alpha-induced matrix metalloproteinase-9 in human monocytes/macrophages. Clin Exp Allergy 2007, 37:608-614.
19. Barnes P. Cytokines as mediators of chronic asthma. Am J Respir Crit Care Med 1994, 150:S42-49.
20. Roche W., Beasley R., Williams J., Holgate S. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989, 1:520-524.
21. Barbato A., Turato G., Baraldo S., Bazzan E., Calabrese F., Tura M., et al. Airway inflammation in childhood asthma. Am J Respir Crit Care Med 2003, 2168:798-803.
22. Ichiyama T., Hasegawa M., Ueno Y., Makata H., Matsubara T., Furukawa S. Cysteinyl leukotrienes induce monocyte chemoattractant protein 1 in human monocytes/macrophages. Clin Exp Allergy 2005, 35:1214-1219.
23. Ichiyama T., Hasegawa S., Umeda M., Terai K., Matsubara T., Furukawa S. Pranlukast inhibits NF-kappa B activation in human monocytes/macrophages and T cells. Clin Exp Allergy 2003, 233:802-807.
24. Maeba S., Ichiyama T., Ueno Y., Makata H., Matsubara T., Furukawa S. Effect of montelukast on nuclear factor kappa B activation and proinflammatory molecules. Ann Allergy Asthma Immunol 2005, 94:670-674.
25. Feng C., Mery A.G., Beller E.M., Favot C., Boyce J.A. Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor. J Immunol 2004, 173:7539-7547.
26. Ciccarelli R., D'Alimonte I., Santavenere C., D'Auro M., Ballerini P., Nargi E. Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via cys-LT1 receptors and mitogen-activated protein kinase pathway. Eur J Neurosci 2004, 20:1514-1524.
27. Drazen J., Austen K., Lewis R., Clark D., Goto G., Marfat A., et al. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci USA 1980, 77:4354-4358.
28. Marom Z., Shelhamer J., Bach M., Morton D., Kaliner M. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982, 126:449-451.
29. Woodward D., Wasserman M., Weichman B. Investigation of leukotriene involvement in the vasopermeability response associated with guinea pig tracheal anaphylaxis: comparison with cutaneous anaphylaxis. Eur J Pharmacol 1983, 193:9-19.
30. Collins P., Connolly D., Williams T. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol 1993, 109:195-199.
31. Lee Y., Lee H. Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol 2001, 107:1106.
32. Chetta A., Zanini A., Foresi A., D'Ippolito R., Tipa A., Castagnaro A., et al. Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. Clin Exp Allergy 2005, 35:1437-1442.
33. Thomas P., Yates D., Barnes P. Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995, 152:76-80.
34. Thomas P., Heywood G. Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. Thorax 2002, 57:774-778.
35. Gosset P., Tsicopoulos A., Wallaert B., Vannimenus C., Joseph M., Tonnel A., et al. Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol 1991, 88:561-571.
36. Broide D., Lotz M., Cuomo A., Coburn D., Federman E., Wasserman S. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992, 89:958-967.
37. Berry M., Hargadon B., Shelley M., Parker D., Shaw D., Green R., et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006, 354:697-708.
38. Erzurum S. Inhibition of tumor necrosis factor alpha for refractory asthma. N Engl J Med 2006, 354:754-758.
39. Howarth P., Babu K., Arshad H., Lau L., Buckley M., McConnell W., et al. Tumour necrosis factor (TNF alpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005, 60:1012-1018.
40. Nakashima M.K.M., Uematsu T., Tsubokura S. A phase I clinical study of leukotriene C4, D4, and E4 receptor antagonist; ONO-1078 in healthy volunteers. Rinsho Iyaku 1993, 9:3-29. (in Japanese).
41. Lynch K., O'Neill G., Liu Q., Im D., Sawyer N., Metters K., et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999, 399:789-793.
42. Brown L., Berse B., Jackman R., Tognazzi K., Manseau E., Senger D., et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993, 53:4727-4735.
43. Olson T., Mohanraj D., Carson L., Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 1994, 54:276-280.
44. Plate K., Breier G., Weich H., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992, 359:845-848.